Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Charles River, AZ Alliance Delivers Respiratory Candidate | Contract Pharma

What are you searching for?

Sign in
Breaking News

Charles River, AZ Alliance Delivers Respiratory Candidate

Successfully nominates oral drug candidate for preclinical development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Charles River Labs’ drug discovery collaboration with AstraZeneca has delivered an undisclosed, oral respiratory candidate for progression into preclinical development.
 
AstraZeneca and BioFocus, now part of Charles River Discovery Services, have been working collaboratively since March 2012 on a respiratory project, under which BioFocus provided much of the discovery work from its facilities near Cambridge, UK and Leiden, NL. This project has successfully nominated an oral drug candidate for preclinical development.
 
“We are extremely pleased AstraZeneca chose to partner with Charles River for its early drug discovery work,” said David Smith, corporate vice president, Early Discovery, Charles River. “The recognition this project received from the AstraZeneca Innovative Medicines team is a testament to our collaborative approach to partner programs.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics